Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass
10.1111/apha.13516
Saved in:
Main Authors: | Looijaard, Stephanie MLM, Hekkert, Miriam L te Lintel, Wust, Rob C, Otten, Rene HJ, Meskers, Carel GM, Maier, Andrea B |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Language: | English |
Published: |
WILEY
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/234898 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Myostatin is a procachectic growth factor during postnatal myogenesis
by: McFarlane, C., et al.
Published: (2015) -
Current knowledge and practice of Australian and New Zealand health-care professionals in sarcopenia diagnosis and treatment: Time to move forward!
by: Yeung, Suey SY, et al.
Published: (2022) -
Association between malnutrition and stages of sarcopenia in geriatric rehabilitation inpatients: RESORT
by: Verstraeten, L. M. G., et al.
Published: (2022) -
Single Physical Performance Measures Cannot Identify Geriatric Outpatients with Sarcopenia
by: Looijaard, SMLM, et al.
Published: (2022) -
Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Community-Dwelling Older Adults in Singapore.
by: Afandy, Nathania Octaviani, et al.
Published: (2021)